Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin duration in high-risk community-acquired pneumonia
NCT03609099Phase 4Unknown
- Start
- Feb 2019
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
A Phase 4 trial of moxifloxacin in community acquired pneumonia (CAP). Status: unknown.
02
Drugs
moxifloxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT03609099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03609099.